South Dakota Investment Council’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.73M Sell
84,062
-3,208
-4% -$264K 0.13% 155
2025
Q4
$7.44M Sell
87,270
-34,835
-29% -$2.86M 0.14% 145
2025
Q3
$9.5M Sell
122,105
-48,952
-29% -$3.82M 0.18% 117
2025
Q2
$13.4M Sell
171,057
-60,912
-26% -$4.54M 0.26% 85
2025
Q1
$16.8M Sell
231,969
-6,050
-3% -$433K 0.34% 56
2024
Q4
$17.6M Sell
238,019
-3,600
-1% -$252K 0.35% 56
2024
Q3
$15.9M Sell
241,619
-4,200
-2% -$305K 0.31% 63
2024
Q2
$22.7M Sell
245,819
-11,781
-5% -$1.04M 0.47% 35
2024
Q1
$24.6M Hold
257,600
0.51% 32
2023
Q4
$19.6M Buy
257,600
+33,896
+15% +$2.36M 0.42% 41
2023
Q3
$15.5M Sell
223,704
-14,765
-6% -$1.19M 0.35% 53
2023
Q2
$22.5M Sell
238,469
-12,317
-5% -$1.07M 0.47% 35
2023
Q1
$20.7M Buy
250,786
+45,400
+22% +$3.57M 0.44% 40
2022
Q4
$15.3M Buy
205,386
+164,599
+404% +$12.7M 0.34% 60
2022
Q3
$3.37M Hold
40,787
0.08% 213
2022
Q2
$3.88M Hold
40,787
0.09% 207
2022
Q1
$4.8M Sell
40,787
-13,711
-25% -$1.54M 0.1% 192
2021
Q4
$7.06M Hold
54,498
0.12% 162
2021
Q3
$6.17M Hold
54,498
0.11% 177
2021
Q2
$5.64M Sell
54,498
-2,260
-4% -$213K 0.1% 196
2021
Q1
$4.75M Buy
56,758
+170
+0.3% +$14.4K 0.08% 219
2020
Q4
$5.16M Hold
56,588
0.1% 192
2020
Q3
$4.52M Sell
56,588
-370
-0.6% -$28.9K 0.1% 184
2020
Q2
$3.94M Hold
56,958
0.09% 192
2020
Q1
$3.58M Buy
56,958
+810
+1% +$58.4K 0.1% 174
2019
Q4
$4.37M Sell
56,148
-4,602
-8% -$359K 0.09% 198
2019
Q3
$4.45M Buy
60,750
+4,350
+8% +$306K 0.09% 213
2019
Q2
$3.47M Hold
56,400
0.07% 206
2019
Q1
$3.6M Sell
56,400
-39,600
-41% -$2.26M 0.08% 206
2018
Q4
$4.9M Hold
96,000
0.12% 152
2018
Q3
$5.57M Sell
96,000
-9,300
-9% -$455K 0.12% 148
2018
Q2
$5.11M Hold
105,300
0.11% 159
2018
Q1
$4.9M Sell
105,300
-18,600
-15% -$808K 0.11% 147
2017
Q4
$4.66M Sell
123,900
-6,300
-5% -$231K 0.1% 154
2017
Q3
$4.74M Hold
130,200
0.1% 166
2017
Q2
$5.13M Hold
130,200
0.11% 164
2017
Q1
$4.08M Buy
130,200
+13,800
+12% +$432K 0.08% 179
2016
Q4
$3.64M Buy
116,400
+32,400
+39% +$1.05M 0.08% 195
2016
Q3
$3.38M Hold
84,000
0.07% 212
2016
Q2
$2.79M Hold
84,000
0.06% 230
2016
Q1
$2.47M Sell
84,000
-56,400
-40% -$1.56M 0.05% 250
2015
Q4
$3.7M Sell
140,400
-60,000
-30% -$1.56M 0.08% 189
2015
Q3
$4.75M Hold
200,400
0.11% 148
2015
Q2
$4.76M Hold
200,400
0.1% 158
2015
Q1
$4.76M Hold
200,400
0.09% 157
2014
Q4
$4.25M Sell
200,400
-57,000
-22% -$1.15M 0.08% 168
2014
Q3
$4.38M Buy
+257,400
New +$4.06M 0.09% 156

Other funds holding EW

South Dakota Investment Council's EW Position: Q1 2026 in Review

South Dakota Investment Council reduced its Edwards Lifesciences (EW) stake by 3.7% in Q1 2026, selling an estimated $264K and leaving 84,062 shares worth $6.73M. The position accounts for 0.13% of the portfolio, ranked #155.

South Dakota Investment Council first reported a position in EW in Q3 2014 and has held it in 47 quarters since. The position peaked at $24.6M in Q1 2024. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • South Dakota Investment Council held 84,062 shares of Edwards Lifesciences worth $6.73M as of Q1 2026.
  • South Dakota Investment Council sold 3,208 Edwards Lifesciences shares in Q1 2026, an estimated $264K.
  • Edwards Lifesciences made up 0.13% of South Dakota Investment Council's portfolio in Q1 2026, its #155 holding.
  • South Dakota Investment Council first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 47 quarters since.
  • South Dakota Investment Council's Edwards Lifesciences position peaked at $24.6M in Q1 2024.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on South Dakota Investment Council's 13F filing for Q1 2026, filed 18 May 2026.